The Global Access Strategy and Pricing (GASP) Precision Medicine & Lung Cancer Director role directly impacts the ability to achieve business objectives by supporting the development of strategic guidance on access, pricing, optimal reimbursement, launch sequencing, patient value, and evidence generation for the Precision Medicine & Lung Cancer franchise.

The Precision Medicine & Lung Cancer franchise is one of the prioritized Oncology franchises and consists of products recently post DP3, with pre-DP3 indications, and pre-launch and in-line products. The franchise includes the following products: Braftovi, Mektovi, Lorbrena, Xalkori, Sigvotatug Vedotin and PDL1V. The objective for the franchise strategy is to advance the treatment of lung cancer through next-generation backbones of treatment and novel combinations from our internal portfolio and with external combination partners.

This position will function with a ‘One Global Access and Value’ mindset and work in an aligned manner with the Breast GASP team, other GAV colleagues (USMA, HV&E), and Country Access & Value colleagues. The role will be most heavily focused on  indications for Braftovi and Mektovi. This person will support the advancement of the integrated value and access strategy (IVAS) in partnership with the cross functional team and aligned to the brand strategy. The IVAS will optimize the long-term value of the products by optimizing the pricing & access strategy including indication launch sequence and evidence generation plans. The position reports to the GASP Precision Medicine & Lung Cancer Team Lead within GAV.
 

ROLE RESPONSIBILITIES

Lead generation of payer insights and support the translation into clear and cohesive integrated value and access, pricing and evidence generation strategies for key markets to support the Precision Medicine & Lung Cancer FranchiseProvide subject matter expertise and support critical strategic discussions at Senior Leadership forumsDeliver clear recommendations relating to payer strategy, pricing and reimbursement, analogue case studies, evidence generation, data collection and value propositionParticipate in virtual cross functional teams including representing GAV at Commercial Subteams, and at the GPT. Coordinate and lead projects related to specific asset threats and opportunities

Generate & synthesize payer insights

Maintain in-depth understanding of payer regulations, including novel-novel combinations, fixed dose combinations, and needs of all types of payers (e.g. HTA agencies, institutions and patients) in key Pfizer marketsKnowledgeable about US oncology access & pricing landscape, IDM markets, China, Japan, HTA/payer requirements and EU JCASupport assessment and communication of external access trends to anticipate potential challenges and opportunities for the Precision Medicine & Lung franchiseGather and synthesize feedback for development programs with health technology assessment agencies, payers, and relevant patient associations

Develop payer value proposition and drive market access strategy

Support the development of clear and cohesive access, pricing and evidence generation strategy to optimize value of the Precision Medicine & Lung Franchise Lead discussions with Country Health & Value and Payer Channel Access Leads at critical junctures to ensure local insights are integrated into global plans that optimize long-term value for Precision Medicine & Lung FranchiseProvide input into clinical development plans, market access and pricing strategies and recommendations, early HTA advice, early economic models, and evidence generation plans via the Integrated Value & Access PlanSupport alignment efforts with Commercial, CSI, Clinical, Medical, and Asset teams to ensure clinical trial design, real world evidence plan, and commercial strategies reflect payer insights and align with Bold Moves in order to maximize value of the Precision Medicine & Lung FranchiseSupport discussions and early buy-in discussions with senior leadership on price and market access strategy and recommendations to support key business decision pointsSupport development of the IVAS, value proposition and value-based agreement strategy and buy-in from cross-functional stakeholdersDevelop pricing & market access product and country assessments, and run country workshopsSupport analyses and recommendations in partnership with HV&E to influence clinical trial design recommendations (e.g. endpoints, comparators, PROs), development of early economic model, and generation of supplemental evidence (e.g. comparative-effectiveness studies leveraging real-world evidence) to strengthen our value proposition and pricing/access opportunity

Advance functional excellence in Global Market Access

Build and maintain relationships with cross-functional teams including HEOR, Medical, Commercial, CSI and others to drive payer perspective and optimize for reimburseability per critical business needs globally for lung cancerWork efficiently and collaboratively in a highly matrixed environmentDevelop expertise in US, IDM, China markets and launch requirements

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Bachelor's degree minimum required; Advanced degree in a healthcare, business or economic field preferred (PhD, PharmD, MS, MBA, MPH ...)8+ years of experience required with Bachelor’s; 7+ years of experience required with Master’s / MBA; 5+ years of experience required with PharmD / PhD, preferably in pharmaceutical industry or related consulting services, sufficient to have developed an understanding of the global and US payer and market access environmentExperience in developing and executing Pricing & Market Access strategies and deliverables on US and key ex-US markets such as Germany, France, UK, Italy and/or Spain, China, JapanExcellent oral and written English communication skills required

PREFERRED QUALIFICATIONS

Experience working on lung cancer agents globally, and knowledge of HTA and payer requirement is desirable. US, IDM, China, country level HTA and negotiation experience is desirableStrong knowledge and understanding of drug development processPharmaceutical business, including experience in strategy development and interaction with customers.Strong project management abilities (contracting, budgeting, vendor management) essentialDemonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines a=nd rapidly shifting prioritiesExcellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environmentSkilled in functioning within a matrix organization where managing through influence is required and experience of managing people in a cross-cultural environment

Other Job Details:

Last Date to Apply for Job: July 31st, 2025.Ability to travel based on business needs (25%)NOT eligible for Relocation PackageThis position is hybrid and requires working onsite 2 to 3 days per week

The annual base salary for this position ranges from $169,700.00 to $282,900.00.* In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

* The annual base salary for this position in Tampa, FL ranges from $152,700.00 to $254,500.00.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.  These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure.  Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act.  Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government.  If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.  Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  Pfizer is an E-Verify employer.  This position requires permanent work authorization in the United States.

Market Access